Offer - Urjas Oil for just ₹ 1 X
Cilinitab T is an allopathic medicine The correct dosage of Cilinitab T depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Cilinitab T is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Cilinitab T safe for pregnant women?
Pregnant women may get severe side effects after taking Cilinitab T. If you are pregnant, do not take Cilinitab T without a doctor's advice.
Is the use of Cilinitab T safe during breastfeeding?
Cilinitab T may have very limited harmful effects for breastfeeding women.
What is the effect of Cilinitab T on the Kidneys?
Using Cilinitab T does not have any harmful effects on kidneys.
What is the effect of Cilinitab T on the Liver?
Cilinitab T may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Cilinitab T on the Heart?
Very few cases of side effects of Cilinitab T on the heart have been reported.
Cilinitab T should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Cilinitab T unless your doctor advises you to do so -
Is this Cilinitab T habit forming or addictive?
Cilinitab T does not cause addiction.
Interaction between Food and Cilinitab T
When consumed with certain foods, Cilinitab T may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Cilinitab T
Taking Cilinitab T with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)